Cure VCP Disease
Legal Review of Cell Line Licensing and Commercial Use Terms
Clarifies contract terms so we can share research tools and support rare disease cures.
Posted May 7, 2025
Work & Deliverables
We need a lawyer to review an existing licensing agreement for cell lines and explain the terms related to commercialization, research use, and distribution. We’re looking for written or verbal guidance on what the contract allows and what restrictions exist, especially in regard to sale, distribution, or sublicensing. Additionally, we are looking for advice on what to ask for in a new agreement based on the desired use cases of these cell lines and what might be possible.
Cure VCP Disease
Cure VCP Disease, Inc., is a patient advocacy organization dedicated to driving the development of a cure for diseases caused by valosin-containing protein (VCP), including muscle disease, bone disease, and the neurodegenerative diseases ALS, FTD, Parkinson’s, and CMT. Our mission is to unite and fund research while building collaborations and supporting patients within the VCP global community.
Volunteer for this project!
Cure VCP Disease would love your help with this project. Enter your name and email address to get started!
Cure VCP Disease
Cure VCP Disease, Inc., is a patient advocacy organization dedicated to driving the development of a cure for diseases caused by valosin-containing protein (VCP), including muscle disease, bone disease, and the neurodegenerative diseases ALS, FTD, Parkinson’s, and CMT. Our mission is to unite and fund research while building collaborations and supporting patients within the VCP global community.